A lot has changed since I wrote this @LifeSciLeader1 piece on becoming the CEO of Lyndra® Therapeutics, but leadership imperatives like setting the tone for the company are more important than ever. Thanks for the opportunity to share what I've learned, @RFWrightLSL.bit.ly/2zH6oYq

Our team at Lyndra® Therapeutics has shown resiliency through the #COVID19 pandemic and continued to build momentum toward our goal of reinventing medicines. I couldn’t be more proud of the Lyndra team for the milestones we’ve achieved in the first half of 2020. bwnews.pr/3cZzGjf

George Eldridge joins us as our new Chief Financial Officer at Lyndra. George’s 27 years of financial leadership within the biotech industry make him an invaluable addition to our team. businesswire.com/news/home/2020…

Vote for Lyndra Therapeutics to be recognized as the Buzz of BIO in the Private Therapeutic Biotech Category! Cast your vote by December 11 to help us win! Vote Here: bit.ly/CEObuzz21

Today is the last day for you to vote for Lyndra as the Buzz of BIO in the Private Therapeutic Biotech Category! To help us win, vote here: bit.ly/CEObuzz21

Today, our leadership team met with #MA04 Congressman-elect Jake Auchincloss to discuss our new high-tech Town of Lexington, MA manufacturing facility. We thank Congressman-elect Auchincloss for his time and look forward to expanding our role in Massachusetts’ economic growth.

Thanks to Pippa Hudson and Cape Talk Radio in Cape Town, South Africa for having me on this morning to discuss Lyndra’s mission to transform healthcare and patient non-adherence. In case you missed it, listen via the link below.

With patient-driven interest and flexible study design, our investigational Synthetic Biotic for the treatment of #PKU is advancing rapidly within the clinic. Do you qualify? Find out how: bit.ly/2IfDoM1#synbio

In honor of #IWD2021 we're thrilled to feature our newest Board member Lisa Kelly-Croswell alongside Aoifemlbrennan, Dr. Caroline Kurtz & @Dogbluehorse (Trish Hurter) on a panel to discuss female #leadership both in and outside of the workplace. #ChooseToChallenge #synbio

I’m looking forward to speaking Longwood Fund Healthcare Leaders next week centered on MIT with biopharma CEOs, Head of FDA, and leading academics. Join us longwoodhealthcareleaders.com/april2021

I’m very proud of the work the team at Lyndra® Therapeutics is doing to mitigate the most common risk factor for relapse in patients with schizophrenia: medication non-adherence. Click below to learn about the results of our Phase 2 study of LYN-005.

Thanks to Fierce Biotech for this great article article highlighting the results of @Lyndra’s phase 2 study of LYN-005. Read more about LYN-005, our once-weekly treatment for schizophrenia: : fiercebiotech.com/biotech/lyndra…

I’m proud of our team at Lyndra® Therapeutics for their efforts to address significant public health concerns about access to OUD treatment. Read below to learn more about the need for new and improved, patient-friendly treatments for OUD – and how LYN-014 is designed to meet this need.

Here at Lyndra we aim to foster an environment where hard work is met with good times. This weekend, our mission brought a hardworking, collaborative team to our manufacturing facility to keep advancing our pipeline – & a happy hour and home-baked goods! 🍻🧁#WorkHardPlayHard

Lyndra’s CEO Patricia Hurter & President/COO Jessica Ballinger sat down with Natalie Pierce of Gunderson Dettmer to discuss all things Lyndra – from current barriers in oral medicine delivery to how Lyndra’s long-acting oral therapies have the potential to transform the patient experience.

Thank you Patricia Hurter, CEO of Lyndra® Therapeutics, for your career insights in the #lifesciences industry. Check out this episode to hear about their groundbreaking approach to oral #medicine. bit.ly/3qNCGrH #clinicalstage #biotech #drugdelivery #mentalhealth #schizophrenia

Check out my latest article: More than demographics: Diversity, Inclusion and Psychological Safety linkedin.com/pulse/more-tha… via LinkedIn

Thank you to @mallikamarshall of @WBZ | CBS Boston for chatting with me about Lyndra® Therapeutics's LYNX™ drug delivery platform. We’re proud to spread the word about our work creating long-acting oral medications for patients. #Lyndra #Innovation #biotech cbsnews.com/boston/news/wa…

Wayne Koberstein of Life Science Leader met with our CEO Patricia Hurter to discuss the importance of #continuousmanufacturing (CM) and how CM can increase speed of development & allow engineers to adjust processes more efficiently than #batchmanufacturing: lifescienceleader.com/doc/pioneering…

Our CEO Patricia Hurter will be speaking on her career journey and the future of pharma in a virtual “Meet the Leader” session brought to you by American Institute of Chemical Engineers (AIChE). The live webinar will take place on January 25 from 11 am-12pm ET. Register here: lnkd.in/gTHK7yzE #Lyndra #PD2M